Mirikizumab – a new option in the treatment of inflammatory bowel diseases. Prospects in Pharmaceutical Sciences, [S. l.], v. 22, n. 3, p. 178–185, 2024. DOI: 10.56782/pps.262. Disponível em: https://prospects.wum.edu.pl/index.php/pps/article/view/262. Acesso em: 9 nov. 2026.